Low-alcohol wines have become an increasingly popular category within the broader beverage market. Consumers are often drawn to these products for their lower alcohol content, reduced calorie profile, and convenience—particularly when packaged in smaller, more portable formats suited for casual, on-the-go occasions. As demand continues to grow, producers entering this space should be mindful that these products raise unique regulatory considerations, particularly with respect to labeling.
Understanding the Regulatory Framework
In the United States, the labeling of alcohol beverages is generally overseen by the Alcohol and Tobacco Tax and Trade Bureau (“TTB”). However, this framework shifts when it comes to certain low-alcohol wine products.
As a general rule, wines that contain less than 7% alcohol by volume (“ABV”) fall under the primary labeling jurisdiction of the Food and Drug Administration (“FDA”), rather than the TTB. This distinction is critical, as it determines which set of labeling requirements apply to your product.
What Changes Under FDA Jurisdiction?
Unlike traditional wine labels regulated by the TTB, products subject to FDA oversight must comply with food labeling requirements. These typically include:
- A Nutrition Facts Panel
- An ingredient statement
- Allergen disclosures (where applicable)
- Compliance with FDA formatting and labeling conventions*
* Not an exhaustive list
These elements are standard for conventional food and beverage products—such as packaged foods and non-alcoholic beverages—but are not typically required on wines at or above 7% ABV.
This regulatory shift can create confusion for industry members, particularly because FDA labeling rules are not specifically tailored to alcohol beverages. Instead, they are designed for food products more broadly, which can make their application to wine less intuitive.
Practical Challenges for Industry Members
For producers, importers, and distributors, navigating FDA requirements in the context of wine can be complex. Many of the applicable regulations were not written with alcohol products in mind, and there is limited guidance addressing how they should be applied in this context.
As a result, companies entering the low-alcohol wine space should take care to ensure that their labels are fully compliant before going to market. Errors in labeling can lead to costly delays, product holds, or enforcement actions.
TTB Permitting Still Applies
It is important to note that even if a wine falls under FDA labeling jurisdiction, it does not necessarily remove the requirement to obtain appropriate federal permits. Domestic wine producers must still hold a winery permit issued by the TTB to produce wines under 7% ABV.
In other words, while labeling oversight may shift to the FDA for wines under 7% ABV, TTB jurisdiction continues to apply in other key areas, including permitting and certain operational requirements.
Final Thoughts
The distinction between FDA and TTB labeling jurisdiction is a critical consideration for any company producing or marketing low-alcohol wine. Understanding where your product falls—and which regulatory framework applies—is essential to avoiding compliance issues and ensuring a smooth path to market.
Given the nuances involved, early planning and careful review of labeling requirements can save significant time and expense down the line.
How We Can Help
At Lindsey Zahn P.C., we advise alcohol beverage companies on federal and state regulatory compliance, including both Food and Drug Administration and Alcohol and Tobacco Tax and Trade Bureau requirements. We work with clients to review and develop compliant labels, navigate permitting obligations, and address complex regulatory questions across product categories.
If you are developing a low-alcohol wine product or have questions about labeling requirements, we invite you to contact our team to discuss how we can support your business.
📩 Email us at info@zahnlawpc.com
🔗 Visit our Contact Page to get started.